DXCM · DexCom, Inc.
AI read · Good for DXCM
The AI's read
More analysts now see room for DexCom's shares to rise, which supports a positive reading. Four kept Buy or Overweight ratings, and JP Morgan stayed Neutral but raised its estimate too. These are opinions reacting to recent results, not new proof of sales or profit growth.